Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

monafram

 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (2)

Monoclonal AntibodiesPeptide Fragments

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Binding of Coagulation Factor XIII Zymogen to Activated Platelet Subpopulations: Roles of Integrin αIIbβ3 and Fibrinogen.
Factor XIIIa (fXIIIa) is a transglutaminase that plays a crucial role in fibrin clot stabilization and regulation of fibrinolysis… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2016
2016
Glycoprotein IIB-IIIA inhibitor, monafram decelerate the early phase of red blood cells aggregation
It is commonly known that red blood cell (RBC) tendency to reversibly aggregate contribute to the unique flow properties of blood… Expand
  • table 1
  • figure 1
  • figure 2
  • table 2
Is this relevant?
2012
2012
Red blood cells (dis)aggregation: effect of inhibition of fibrinogen binding
There are complex interactions between blood cells, and erythrocytes may enhance platelet aggregation. However, there is a lack… Expand
  • table 1
  • table 2
Is this relevant?
2012
2012
Identification of signal transduction pathways involved in the formation of platelet subpopulations upon activation
Platelets are formed elements of blood. Upon activation, they externalize phosphatidylserine, thus accelerating membrane… Expand
Is this relevant?
2011
2011
EFFICACY AND SAFETY OF GLYCOPROTEIN IIB/IIIA BLOCKER MONOFRAM IN CORONARY STENTING IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
Aim. To study of efficacy and safety of glycoprotein IIb/IIIa blocker monafram in acute ST-segment elevation myocardial… Expand
Is this relevant?
2010
2010
[Glycoprotein IIb-IIIa antagonist Monafram in primary angioplasty of patients with acute coronary syndrome without st segment elevation].
Glycoprotein (GP) llb-llla anagonist monafram is the F(ab)2 fragments of anti GP llb llla monoclonal antibody FraMon (CRC64… Expand
Is this relevant?
2007
2007
Effects of platelet glycoprotein IIb-IIIa number and glycoprotein IIIa Leu33Pro polymorphism on platelet aggregation and sensitivity to glycoprotein IIb-IIIa antagonists
We investigated the influence of glycoprotein (GP) IIIa Leu33Pro polymorphism, platelet GP IIb-IIIa number, and plasma fibrinogen… Expand
Is this relevant?
2005
2005
Ability of Different Glycoprotein IIb-IIIa Ligands to Support Platelet Aggregation Induced by Activating Antibody CRC54
The ability of different ligands of glycoprotein (GP) IIb-IIIa (αIIb/β3-integrin) to support platelet aggregation stimulated by… Expand
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • figure 5
Is this relevant?
2005
2005
[Results of clinical trials of a novel glycoprotein IIb-IIIa antagonist framon in high-risk coronary angioplasty].
New glycoprotein (GP) IIb-IIIa antagonist preparation framon (Monafram), is the F(ab')(2) fragment of a monoclonal antibody… Expand
Is this relevant?
2004
2004
[Antiplatelet effects of glycoproteins IIb-IIIa antagonist monafram].
First Russian glycoprotein (GP) IIb-IIIa antagonist, preparation Monafram, is the F(ab')2 fragment of anti-GP IIb-IIIa monoclonal… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE